Recursion Pharmaceuticals, Inc.
(NASDAQ GS: RXRX)
Rigrodsky Law, P.A. is investigating Recursion Pharmaceuticals, Inc. (“Recursion”) regarding possible breaches of fiduciary duties and other violations of law related to Recursion’s agreement to merge with Exscientia plc.